Skip to main content

Table 5 Prognostic factors for overall survival of 89 MS-LCH patients who received systemic chemotherapy through univariate and multivariate cox regression *Only factors with a P value < 0.1 in univariate analysis were listed

From: Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement

 

Univariate Cox

Multivariate Cox

 

HR (95% CI)

P value

HR (95% CI)

P value

Age at diagnosis

1.080 (1.010–1.155)

0.024

1.051 (0.923–1.197)

0.453

FEV1 ≤ 55%

14.882 (1.339–164.037)

0.028

12.487 (1.131–137.822)

0.039

TLC

0.907 (0.832–0.988)

0.025

0.864 (0.703–1.061)

0.162

Cytarabine based therapy

0.127 (0.024–0.662)

0.014

0.151 (0.009–2.456)

0.184

  1. MS Multisystem disease